Homozygosity at the Candida albicans MTL locus associated with azole resistance

Microbiology
Tige R RustadTheodore C White

Abstract

Antifungal drug resistance in the pathogenic fungus Candida albicans is a serious threat to the growing population of immunocompromised patients. This study describes a significant correlation between loss of heterozygosity at the C. albicans mating-type-like (MTL) locus and resistance to azole antifungals. A pool of 96 clinical isolates consisting of 50 azole-resistant or susceptible dose-dependent isolates and 46 azole-susceptible isolates was screened by PCR for the presence of MTLa1 and MTLalpha1. These genes were used as markers for the MTLa and MTLalpha loci. Both loci were present in 84 of the isolates. Six isolates failed to amplify MTLa1 and six failed to amplify MTLalpha1. Further PCR analysis demonstrated that loss of the MTLa1 and MTLalpha1 genes corresponded to loss of all of the loci-specific genes, resulting in homozygosity at the MTL locus. Southern analysis and single nucleotide polymorphism (SNP) analysis were used to determine that this loss of heterogeneity was due to replacement of one of the MTL loci with a duplicate of the other locus resulting in two homozygous copies of the MTL locus. Of the 12 homozygous isolates, one isolate was sensitive to azole drugs. Statistical analysis of the data demonstrates a...Continue Reading

References

Nov 1, 1994·The Journal of Antimicrobial Chemotherapy·D LawD W Denning
Oct 1, 1995·Current Opinion in Genetics & Development·A D Johnson
Feb 1, 1996·Antimicrobial Agents and Chemotherapy·N H Georgopapadakou, T J Walsh
Jun 1, 1997·Infectious Disease Clinics of North America·W L Wright, R P Wenzel
Nov 14, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K A MarrR A Bowden
Jun 6, 1998·Proceedings of the National Academy of Sciences of the United States of America·G JanbonE Rustchenko
Jun 20, 1998·Clinical Microbiology Reviews·T C WhiteR A Bowden
Jun 29, 1999·Journal of Bacteriology·V PerepnikhatkaE Rustchenko
Dec 20, 2000·Antimicrobial Agents and Chemotherapy·K A MarrT C White

❮ Previous
Next ❯

Citations

Mar 1, 2012·Trends in Genetics : TIG·Judith Berman, Lilach Hadany
Mar 13, 2008·Fungal Genetics and Biology : FG & B·Timothy J Lott, Robin T Scarborough
Jun 9, 2007·Molecular Microbiology·Wei WuDavid R Soll
Nov 24, 2004·Current Opinion in Microbiology·P T Magee, Beatrice B Magee
Sep 24, 2004·Diagnostic Microbiology and Infectious Disease·Gustavo H GoldmanArnaldo L Colombo
Dec 7, 2014·Journal of Medical Microbiology·Olatz AlbainaMaría D Moragues
Sep 9, 2015·BMC Genomics·Sharanya ChatterjeeUtpal S Tatu
Aug 4, 2015·Future Microbiology·Martin Zavrel, Theodore C White
Sep 5, 2006·Current Biology : CB·Joseph Heitman
Aug 12, 2009·Fungal Genetics and Biology : FG & B·Joachim Morschhäuser
May 6, 2014·Frontiers in Physiology·Sanjoy Paul, W Scott Moye-Rowley
Feb 22, 2007·FEMS Yeast Research·Elena Rustchenko
Dec 22, 2011·International Journal of Microbiology·Patrick VandeputteAlix T Coste
Sep 29, 2004·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Marie-Elisabeth BougnouxChristophe d'Enfert
Jul 19, 2002·Yeast
Apr 26, 2008·The Journal of Antimicrobial Chemotherapy·Theresa S RichardsTheodore C White
Jan 8, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Juergen Loeffler, David A Stevens
Dec 22, 2009·Future Microbiology·Frank C Odds
Dec 3, 2002·Nature Reviews. Genetics·Judith Berman, Peter E Sudbery
Jun 3, 2016·Microbiology and Molecular Biology Reviews : MMBR·David R Soll, Karla J Daniels
Mar 28, 2008·Molecular Microbiology·Anna SelmeckiJudith Berman
May 3, 2011·Biological & Pharmaceutical Bulletin·Feng YangYuan-Ying Jiang
Jan 26, 2020·Microorganisms·Sofia Costa-de-Oliveira, Acácio G Rodrigues
Mar 26, 2003·Antimicrobial Agents and Chemotherapy·Claude PujolDavid R Soll
May 25, 2010·Eukaryotic Cell·Anna SelmeckiJudith Berman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.